Sun Pharmaceutical Industries has announced the acquisition of a 15.91% stake in Krystal Biotech for $7m.
Both companies involved in the acquisition are based in India.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Chinese pharmaceutical company Northeast Pharmaceutical Group plans to acquire another pharmaceutical company based in China through its wholly owned subsidiary for CNY120m ($17.82m).
UK-based specialist pharmaceutical company Mallinckrodt plans to acquire US-based pharmaceutical company InfaCare Pharmaceutical Corporation for an initial upfront payment of $80m.
Mallinckrodt will make additional payments of up to $345m upon achieving regulatory and sales milestones.
The acquisition will enable Mallinckrodt to expand its paediatric product portfolio.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataFormosa Laboratories plans to acquire Activus Pharma through its subsidiary Formosa Pharmaceuticals from Sosei Group Corporation.
Formosa is an active pharmaceutical ingredients (APIs) manufacturer based in Taiwan, while both Activus Pharma and Sosei Group Corporation are pharmaceutical companies based in Japan.
